FDA approves Xyzal for younger children

(Forbes) UPDATED 2009-08-25

The U.S. Food and Drug Administration has approved the once-daily allergy medication Xyzal for young children. The medication is approved to treat indoor allergies and hives in children six months and older, and outdoor allergies for children over the age of two. Previously, the medication was approved to treat allergy symptoms only in children over the age of six. Read full story >

See all Allergy News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

FDA approves Xyzal for younger children

People who read this also read...

What the community is saying...

Q & A on Drug Reactions: Was it an Allergic or Non-Allergic Type of Reaction?

James Thompson, MD